WBA Quote, Financials, Valuation and Earnings

CVS Health has a net margin of -7.39% compared to Walgreens Boots Alliance's net margin of 1.68%. Walgreens Boots Alliance's return on equity of -46.98% beat CVS Health's return on equity of 6.12%.

Walgreens Boots Alliance has a consensus price target of $12.29, signalling upside risk potential of 12.67%. On the other hand CVS Health has an analysts' consensus of $73.26 which suggests that it could grow by 5.86%. Given that Walgreens Boots Alliance has higher upside potential than CVS Health, analysts believe Walgreens Boots Alliance is more attractive than CVS Health.

Walgreens Boots Alliance has a beta of 0.671, which suggesting that the stock is 32.877% less volatile than S&P 500. In comparison CVS Health has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.622%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 9.17%. CVS Health offers a yield of 3.84% to investors and pays a quarterly dividend of $0.67 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. CVS Health pays out 73.1% of its earnings as a dividend. CVS Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Walgreens Boots Alliance quarterly revenues are $38.6B, which are smaller than CVS Health quarterly revenues of $97.7B. Walgreens Boots Alliance's net income of -$2.9B is lower than CVS Health's net income of $1.6B. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while CVS Health's PE ratio is 18.91x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.06x versus 0.23x for CVS Health. Usually stocks with elevated PS ratios are considered overvalued.

HealthWarehouse.com has a net margin of -7.39% compared to Walgreens Boots Alliance's net margin of 0.82%. Walgreens Boots Alliance's return on equity of -46.98% beat HealthWarehouse.com's return on equity of --.

Walgreens Boots Alliance has a consensus price target of $12.29, signalling upside risk potential of 12.67%. On the other hand HealthWarehouse.com has an analysts' consensus of -- which suggests that it could grow by 711.49%. Given that HealthWarehouse.com has higher upside potential than Walgreens Boots Alliance, analysts believe HealthWarehouse.com is more attractive than Walgreens Boots Alliance.

Walgreens Boots Alliance has a beta of 0.671, which suggesting that the stock is 32.877% less volatile than S&P 500. In comparison HealthWarehouse.com has a beta of 0.467, suggesting its less volatile than the S&P 500 by 53.254%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 9.17%. HealthWarehouse.com offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. HealthWarehouse.com pays out -- of its earnings as a dividend.

Walgreens Boots Alliance quarterly revenues are $38.6B, which are larger than HealthWarehouse.com quarterly revenues of $9M. Walgreens Boots Alliance's net income of -$2.9B is lower than HealthWarehouse.com's net income of $73.8K. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while HealthWarehouse.com's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.06x versus 0.18x for HealthWarehouse.com. Usually stocks with elevated PS ratios are considered overvalued.

Moderna has a net margin of -7.39% compared to Walgreens Boots Alliance's net margin of -117.16%. Walgreens Boots Alliance's return on equity of -46.98% beat Moderna's return on equity of -29.09%.

Walgreens Boots Alliance has a consensus price target of $12.29, signalling upside risk potential of 12.67%. On the other hand Moderna has an analysts' consensus of $51.31 which suggests that it could grow by 91.45%. Given that Moderna has higher upside potential than Walgreens Boots Alliance, analysts believe Moderna is more attractive than Walgreens Boots Alliance.

Walgreens Boots Alliance has a beta of 0.671, which suggesting that the stock is 32.877% less volatile than S&P 500. In comparison Moderna has a beta of 2.231, suggesting its more volatile than the S&P 500 by 123.128%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 9.17%. Moderna offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. Moderna pays out -- of its earnings as a dividend.

Walgreens Boots Alliance quarterly revenues are $38.6B, which are larger than Moderna quarterly revenues of $956M. Walgreens Boots Alliance's net income of -$2.9B is lower than Moderna's net income of -$1.1B. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while Moderna's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.06x versus 3.25x for Moderna. Usually stocks with elevated PS ratios are considered overvalued.

SunLink Health Systems has a net margin of -7.39% compared to Walgreens Boots Alliance's net margin of -16.93%. Walgreens Boots Alliance's return on equity of -46.98% beat SunLink Health Systems's return on equity of 7.13%.

Walgreens Boots Alliance has a consensus price target of $12.29, signalling upside risk potential of 12.67%. On the other hand SunLink Health Systems has an analysts' consensus of -- which suggests that it could fall by --. Given that Walgreens Boots Alliance has higher upside potential than SunLink Health Systems, analysts believe Walgreens Boots Alliance is more attractive than SunLink Health Systems.

Walgreens Boots Alliance has a beta of 0.671, which suggesting that the stock is 32.877% less volatile than S&P 500. In comparison SunLink Health Systems has a beta of 1.220, suggesting its more volatile than the S&P 500 by 21.993%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 9.17%. SunLink Health Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. SunLink Health Systems pays out -- of its earnings as a dividend.

Walgreens Boots Alliance quarterly revenues are $38.6B, which are larger than SunLink Health Systems quarterly revenues of $7.9M. Walgreens Boots Alliance's net income of -$2.9B is lower than SunLink Health Systems's net income of -$1.3M. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while SunLink Health Systems's PE ratio is 6.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.06x versus 0.19x for SunLink Health Systems. Usually stocks with elevated PS ratios are considered overvalued.